Comparison of 1‐day versus 3‐day intravenous terlipressin in cirrhosis patients with variceal bleeding: A pilot randomised controlled trial
Manas Vaishnav,
Sagnik Biswas,
Abhishek Shenoy
et al.
Abstract:SummaryBackgroundIn cirrhosis patients with acute variceal bleeding (AVB), the optimal duration of vasoconstrictor therapy after endoscopic haemostasis is unclear.AimsWe aimed to compare efficacy of 1‐day versus 3‐day terlipressin therapy in cirrhosis patients with AVB post‐endoscopic intervention. The primary objective was to compare rebleeding at 5 days between the two arms. Secondary objectives included rebleeding and mortality rates at 6 weeks.MethodsIn this open‐label, randomised controlled trial, cirrhos… Show more
“…We thank Nedumannil et al 1 for their comments on our clinical trial. 2 In recent times, there has been a change in the management protocols of acute variceal bleeding (AVB) in cirrhosis proposed by various expert societies, promoting abbreviated courses of vasoactive (VA) therapy in a select subgroup of patients with liver cirrhosis. 3 Multiple clinical trials have shown the efficacy of a shorter duration of VA drugs to be similar to that of a conventionally accepted duration of 3-5 days, in terms of rebleeding rates and 6-week mortality.…”
Section: Letter: Shorter Duration Of Intravenous Terlipressin For Var...mentioning
LINKED CONTENTThis article is linked to Vaishnav et al papers. To view these articles, visit https://doi.org/10.1111/apt.17868 and https://doi.org/10.1111/apt.17976
“…We thank Nedumannil et al 1 for their comments on our clinical trial. 2 In recent times, there has been a change in the management protocols of acute variceal bleeding (AVB) in cirrhosis proposed by various expert societies, promoting abbreviated courses of vasoactive (VA) therapy in a select subgroup of patients with liver cirrhosis. 3 Multiple clinical trials have shown the efficacy of a shorter duration of VA drugs to be similar to that of a conventionally accepted duration of 3-5 days, in terms of rebleeding rates and 6-week mortality.…”
Section: Letter: Shorter Duration Of Intravenous Terlipressin For Var...mentioning
LINKED CONTENTThis article is linked to Vaishnav et al papers. To view these articles, visit https://doi.org/10.1111/apt.17868 and https://doi.org/10.1111/apt.17976
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.